Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Communiqué de presse : Sarclisa approuvé au Japon pour le traitement du myélome multiple nouvellement diagnostiqué Sarclisa approuvé au Japon pour...
Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Approval offers access to new...
Press Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Sarclisa approved in Japan for patients with newly...
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease ECCO 2025: new duvakitug...
ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New...
Communiqué de presse : ECCO 2025 : de nouvelles données sur le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le...
New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all...
Communiqué de presse : Sanofi et CD&R annoncent la signature de l’accord d’achat des actions d’Opella Sanofi et CD&R annoncent la...
Sanofi and CD&R sign Opella share purchase agreement Paris, February 19, 2025. Following completion of the...
Press Release: Sanofi and CD&R sign Opella share purchase agreement Sanofi and CD&R sign Opella share purchase agreement Paris, February...
Press Release: Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid Dupixent sBLA accepted for FDA...
Communiqué de presse : La FDA accorde un examen prioritaire à la demande de licence supplémentaire relative au Dupixent pour le traitement ciblé...
Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid If approved...
Communiqué de presse : Dépôt du Document d’Enregistrement Universel 2024, contenant le Rapport Financier Annuel, et du « Form 20-F » américain...
Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Filing of...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지